Check Out What Whales Are Doing With CVS
Portfolio Pulse from Benzinga Insights
A significant investor has taken a bearish stance on CVS Health (NYSE:CVS), with 54% of the investors opening trades with bearish expectations. The whales have been targeting a price range from $70.0 to $77.5 for CVS Health over the last 3 months. The price of CVS is currently down -0.25% at $75.47. Mizuho, JP Morgan, and Barclays have maintained their Buy and Overweight ratings on CVS Health, with price targets of $88, $106, and $89 respectively.
July 26, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bearish stance taken by significant investors on CVS Health. Price targets set by Mizuho, JP Morgan, and Barclays are $88, $106, and $89 respectively.
The bearish stance taken by significant investors indicates a potential downward pressure on the stock price. However, the maintained positive ratings and high price targets by Mizuho, JP Morgan, and Barclays suggest a positive outlook in the longer term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100